Page last updated: 2024-08-22

sodium thiosulfate and gadolinium dtpa

sodium thiosulfate has been researched along with gadolinium dtpa in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hayden, MR; Karuparthi, PR; Khanna, R; Saab, G; Yerram, P	1
Marckmann, P; Nielsen, AH; Sloth, JJ	1

Other Studies

2 other study(ies) available for sodium thiosulfate and gadolinium dtpa

Article	Year
Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure--role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate. Clinical journal of the American Society of Nephrology : CJASN, 2007, Volume: 2, Issue:2 Topics: Adult; Contrast Media; Female; Fibrosis; Gadolinium DTPA; Humans; Injections, Intravenous; Renal Insufficiency; Thiosulfates	2007
Possibly enhanced Gd excretion in dialysate, but no major clinical benefit of 3-5 months of treatment with sodium thiosulfate in late stages of nephrogenic systemic fibrosis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:10 Topics: Adult; Chelating Agents; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Hemodialysis Solutions; Humans; Magnetic Resonance Imaging; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Renal Insufficiency; Thiosulfates; Time Factors	2008

Article

Year

Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure--role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate.

Clinical journal of the American Society of Nephrology : CJASN, 2007, Volume: 2, Issue:2

Topics: Adult; Contrast Media; Female; Fibrosis; Gadolinium DTPA; Humans; Injections, Intravenous; Renal Insufficiency; Thiosulfates

2007

Possibly enhanced Gd excretion in dialysate, but no major clinical benefit of 3-5 months of treatment with sodium thiosulfate in late stages of nephrogenic systemic fibrosis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:10

Topics: Adult; Chelating Agents; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Hemodialysis Solutions; Humans; Magnetic Resonance Imaging; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Renal Insufficiency; Thiosulfates; Time Factors

2008